SEVERE ACIDOSIS AND ITS ASSOCIATION WITH MORTALITY IN SEPTIC SHOCK PATIENTS

Tú Nguyễn Ngọc, Hiếu Kiều Trung, Huy Trần Quang, Khang Đặng Lê Minh, Đạt Huỳnh Phát, Khương Hồ Quang, Ngọc Lê Bảo, Quân Bùi Lê, Thi Đào Thị Cẩm, Trà Đỗ Thu, Vân Lê, Linh Trần Thanh, Biên Lê Hữu Thiện

Main Article Content

Abstract

Background: Severe acidosis is both a consequence and an aggravating factor of hemodynamic disturbances. Objective: This study aimed to determine the prevalence and the association of severe acidosis with mortality, as well as the predictive value of the CAS score in septic shock. Methods: We enrolled all patients aged ≥18 years with septic shock according to Sepsis-3 criteria from November 2022 to June 2023. Severe acidosis was defined as a CAS score ≥2. The primary outcome was in-hospital mortality; secondary outcomes included 3-day early mortality and organ support-free days. ROC analysis was used to evaluate the predictive ability of the CAS score for mortality. Logistic regression and Cox regression analyses were performed to assess the association between severe acidosis and mortality. Results: A total of 93 patients were analyzed. The predictive ability of the CAS score was comparable to blood lactate, with poor prediction of in-hospital mortality but fair prediction of 3-day mortality. Patients with severe acidosis (48.4%) had higher mortality rates, and fewer organ support-free days compared to those without severe acidosis. Severe acidosis was associated with 3-day mortality (aHR = 3.21, 95%CI 1.27–8.14) after adjustment for lactate levels, SOFA scores, and vasopressor doses, but was not associated with in-hospital mortality. Conclusion: Severe acidosis is common in septic shock and is associated with 3-day mortality and increased need for organ support. The CAS score predicts 3-day mortality better than in-hospital mortality, with an accuracy comparable to that of blood lactate.

Article Details

References

1. Jung B, Rimmele T, Le Goff C, et al. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care Lond Engl. 2011;15(5):R238. doi:10.1186/cc10487
2. Mochizuki K, Fujii T, Paul E, Anstey M, Pilcher DV, Bellomo R. Early metabolic acidosis in critically ill patients: a binational multicentre study. Crit Care Resusc J Australas Acad Crit Care Med. 2021;23(1): 67-75. doi:10.51893/2021. 1.OA6
3. Jentzer JC, Kashani KB, Wiley BM, et al. Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock. Shock Augusta Ga. 2022;57(1): 31-40. doi:10.1097/SHK. 0000000000001812
4. Mallat J, Michel D, Salaun P, Thevenin D, Tronchon L. Defining metabolic acidosis in patients with septic shock using Stewart approach. Am J Emerg Med. 2012;30(3):391-398. doi:10.1016/j.ajem.2010.11.039
5. Fujii T, Udy AA, Nichol A, et al. Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: An international observational study. Crit Care Lond Engl. 2021;25(1):45. doi:10.1186/s13054-020-03431-2
6. Jaber S, Paugam C, Futier E, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Lond Engl. 2018;392(10141): 31-40. doi:10.1016/ S0140-6736(18)31080-8
7. Jentzer JC, Schrage B, Patel PC, et al. Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock. J Am Heart Assoc. 2022;11(9):e024932. doi:10.1161/JAHA. 121.024932
8. Noritomi DT, Soriano FG, Kellum JA, et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care Med. 2009;37(10):2733-2739. doi:10.1097/ccm.0b013e3181a59165